Suppr超能文献

天冬酰胺-61和天冬酰胺-109对人血管生成素血管生成活性的重要性。

Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogenin.

作者信息

Hallahan T W, Shapiro R, Strydom D J, Vallee B L

机构信息

Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, Boston, Massachusetts 02115.

出版信息

Biochemistry. 1992 Sep 1;31(34):8022-9. doi: 10.1021/bi00149a036.

Abstract

Two distinct regions of angiogenin are critical for angiogenic activity: a catalytic site capable of cleaving RNA and a noncatalytic site, encompassing residues 60-68, which may bind to an endothelial cell-surface receptor [Hallahan, T. W., Shapiro, R., & Vallee, B. L. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 2222-2226]. We have now shown that Asn-61 is an essential residue within the cell-binding site and that in addition a segment containing Asn-109 is part of this site. Both asparagines undergo nonenzymatic deamidation during long-term storage or treatment at alkaline pH. While the isolated desamido-61 and desamido-109 derivatives retain nearly full enzymatic activity, their angiogenic activity on the chicken embryo chorioallantoic membrane is markedly attenuated and they do not inhibit angiogenin-induced neovascularization. Tryptic peptide mapping and Edman degradation demonstrate that the isolated deamidated derivatives primarily contain isoaspartic rather than aspartic acid at the positions in question (83% for desamido-61, greater than 99% for desamido-109). Aspartic acid replacement of Asn-61 and Asn-109 by site-directed mutagenesis results in the same ribonucleolytic and angiogenic activities as those of the spontaneous deamidation products. However, the aspartyl derivatives differ strikingly from their isoaspartyl counterparts in that they do inhibit angiogenin-induced angiogenesis. These results indicate that the combination of ribonucleolytic activity and receptor-binding capacity is not sufficient for angiogenic activity and that Asn-61 and Asn-109 within the noncatalytic site are required for some additional function, as yet undefined.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

血管生成素的两个不同区域对血管生成活性至关重要

一个能够切割RNA的催化位点和一个包含60 - 68位残基的非催化位点,该非催化位点可能与内皮细胞表面受体结合[哈勒汉,T. W.,夏皮罗,R.,& 瓦利,B. L.(1991年)美国国家科学院院刊88,2222 - 2226]。我们现已表明,天冬酰胺-61是细胞结合位点内的一个必需残基,此外,包含天冬酰胺-109的一段序列也是该位点的一部分。在长期储存或碱性pH处理过程中,这两个天冬酰胺都会发生非酶促脱酰胺作用。虽然分离得到的脱酰胺-61和脱酰胺-109衍生物几乎保留了全部酶活性,但它们在鸡胚绒毛尿囊膜上的血管生成活性明显减弱,且它们不抑制血管生成素诱导的新血管形成。胰蛋白酶肽图谱分析和埃德曼降解表明,分离得到的脱酰胺衍生物在相关位置主要含有异天冬氨酸而非天冬氨酸(脱酰胺-61为83%,脱酰胺-109大于99%)。通过定点诱变将天冬酰胺-61和天冬酰胺-109替换为天冬氨酸,产生的核糖核酸酶活性和血管生成活性与自发脱酰胺产物相同。然而,天冬氨酸衍生物与它们的异天冬氨酸对应物显著不同,因为它们确实能抑制血管生成素诱导的血管生成。这些结果表明,核糖核酸酶活性和受体结合能力的组合不足以产生血管生成活性,非催化位点内的天冬酰胺-61和天冬酰胺-109对于某种尚未明确的额外功能是必需的。(摘要截短至250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验